HRT Financial’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

HRT Financial’s Portfolio RVLP Stock Details RVLP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-31,688	Closed	-$2K	–	3360
2023 Q3	$2K	Buy	+31,688	New	+$9.13K	﹤0.01%	2265
2021 Q4	–	Sell	-22,866	Closed	-$67K	–	4342
2021 Q3	$67K	Sell	22,866 -13,195	-37%	-$44.4K	﹤0.01%	2993
2021 Q2	$108K	Buy	+36,061	New	+$110K	﹤0.01%	2586

Other funds holding RVLP

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

HRT Financial's RVLP Position: Q4 2023 in Review

HRT Financial sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 31,688 shares — an estimated $2K sold.

HRT Financial first reported a position in RVLP in Q2 2021 and held it in 3 quarters. The position peaked at $108K in Q2 2021. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

HRT Financial reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
HRT Financial sold 31,688 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $2K.
HRT Financial first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q2 2021 and held it in 3 quarters.
HRT Financial's RVL Pharmaceuticals plc Ordinary Shares position peaked at $108K in Q2 2021.
3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.